| Titolo |
Pubblicato in |
Anno |
| Long-term efficacy of lipoprotein apheresis and lomitapide in the treatment of homozygous familial hypercholesterolemia (HoFH): a cross-national retrospective survey |
ORPHANET JOURNAL OF RARE DISEASES |
2021 |
| Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) |
THE LANCET |
2021 |
| Evaluation of contemporary treatment of high- and very high-risk patients for the prevention of cardiovascular events in Europe – Methodology and rationale for the multinational observational SANTORINI study |
ATHEROSCLEROSIS PLUS |
2021 |
| Lomitapide does not alter PCSK9 and Lp(a) levels in homozygous familial hypercholesterolemia patients: Analysis on cytokines and lipid profile |
ATHEROSCLEROSIS PLUS |
2021 |
| Non-high-density lipoprotein cholesterol versus low-density lipoprotein cholesterol in clinical practice: ANMCO position paper |
JOURNAL OF CARDIOVASCULAR MEDICINE |
2021 |
| Dislipidemia: i nuovi target e importanza
delle terapie di associazione |
GIORNALE ITALIANO DI CARDIOLOGIA |
2021 |
| Evolving trend in the management of heterozygous familial hypercholesterolemia in Italy: a retrospective, single center, observational study |
NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES |
2020 |
| Hdl-mediated cholesterol efflux and plasma loading capacities are altered in subjects with metabolically-but not genetically driven non-alcoholic fatty liver disease (Nafld) |
BIOMEDICINES |
2020 |
| Evolocumab in pediatric heterozygous familial hypercholesterolemia |
NEW ENGLAND JOURNAL OF MEDICINE |
2020 |
| Impact of prior statin use on clinical outcomes in COVID-19 patients: data from tertiary referral hospitals during COVID-19 pandemic in Italy |
JOURNAL OF CLINICAL LIPIDOLOGY |
2020 |
| Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real-life setting: the PROSISA Study |
JOURNAL OF INTERNAL MEDICINE |
2020 |
| Progression of chronic kidney disease in familial LCAT deficiency: a follow-up of the Italian cohort |
JOURNAL OF LIPID RESEARCH |
2020 |
| High TG to HDL ratio plays a significant role on atherosclerosis extension in prediabetes and newly diagnosed type 2 diabetes subjects |
DIABETES/METABOLISM RESEARCH AND REVIEWS |
2020 |
| Proportion of High-Risk/Very High-Risk Patients in Europe with Low-Density Lipoprotein Cholesterol at Target According to European Guidelines: A Systematic Review |
ADVANCES IN THERAPY |
2020 |
| Lipid Lowering Treatment and Eligibility for PCSK9 Inhibition in Post-Myocardial Infarction Patients in Italy: Insights from Two Contemporary Nationwide Registries |
CARDIOVASCULAR THERAPEUTICS |
2020 |
| ANGPTL3 deficiency alters the lipid profile and metabolism of cultured hepatocytes and human lipoproteins |
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS |
2020 |
| Association of hypertriglyceridemia with all-cause mortality and atherosclerotic cardiovascular events in a low-risk italian population: The TG-REAL Retrospective Cohort Analysis |
JOURNAL OF THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR AND CEREBROVASCULAR DISEASE |
2020 |
| Appropriateness criteria for the management of lipid-lowering therapy with alirocumab in high cardiovascular risk patients. The opinion of a multidisciplinary group of Italian experts |
GIORNALE ITALIANO DI CARDIOLOGIA |
2020 |
| Lipoprotein (a): a genetic marker for cardiovascular disease and target for emerging therapies |
JOURNAL OF CARDIOVASCULAR MEDICINE |
2020 |
| Efficacy and Safety of Volanesorsen (ISIS 304801): the Evidence from Phase 2 and 3 Clinical Trials |
CURRENT ATHEROSCLEROSIS REPORTS |
2020 |
